CD8A and type 1 diabetes mellitus: We demonstrate that TAC-mediated delivery of autoantigens in a noninflammatory manner led to delay or prevention of onset of T1D induced by activated diabetogenic BDC2.5 CD4 and NY8.3 CD8 T cells, respectively.